PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LNTH vs. APLS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LNTH and APLS is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

LNTH vs. APLS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lantheus Holdings, Inc. (LNTH) and Apellis Pharmaceuticals, Inc. (APLS). The values are adjusted to include any dividend payments, if applicable.

100.00%200.00%300.00%400.00%JulyAugustSeptemberOctoberNovemberDecember
297.17%
142.48%
LNTH
APLS

Key characteristics

Sharpe Ratio

LNTH:

1.04

APLS:

-0.70

Sortino Ratio

LNTH:

2.06

APLS:

-0.86

Omega Ratio

LNTH:

1.29

APLS:

0.90

Calmar Ratio

LNTH:

1.31

APLS:

-0.55

Martin Ratio

LNTH:

4.34

APLS:

-0.93

Ulcer Index

LNTH:

14.72%

APLS:

42.39%

Daily Std Dev

LNTH:

61.43%

APLS:

55.70%

Max Drawdown

LNTH:

-78.62%

APLS:

-74.65%

Current Drawdown

LNTH:

-26.27%

APLS:

-63.54%

Fundamentals

Market Cap

LNTH:

$6.50B

APLS:

$4.30B

EPS

LNTH:

$6.02

APLS:

-$2.03

Total Revenue (TTM)

LNTH:

$1.50B

APLS:

$715.22M

Gross Profit (TTM)

LNTH:

$979.55M

APLS:

$617.55M

EBITDA (TTM)

LNTH:

$652.18M

APLS:

-$209.70M

Returns By Period

In the year-to-date period, LNTH achieves a 47.02% return, which is significantly higher than APLS's -43.17% return.


LNTH

YTD

47.02%

1M

19.59%

6M

12.35%

1Y

52.18%

5Y*

34.62%

10Y*

N/A

APLS

YTD

-43.17%

1M

29.95%

6M

-15.10%

1Y

-41.32%

5Y*

2.61%

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LNTH vs. APLS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Lantheus Holdings, Inc. (LNTH) and Apellis Pharmaceuticals, Inc. (APLS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for LNTH, currently valued at 1.04, compared to the broader market-4.00-2.000.002.001.04-0.70
The chart of Sortino ratio for LNTH, currently valued at 2.06, compared to the broader market-4.00-2.000.002.004.002.06-0.86
The chart of Omega ratio for LNTH, currently valued at 1.29, compared to the broader market0.501.001.502.001.290.90
The chart of Calmar ratio for LNTH, currently valued at 1.31, compared to the broader market0.002.004.006.001.31-0.55
The chart of Martin ratio for LNTH, currently valued at 4.34, compared to the broader market0.0010.0020.004.34-0.93
LNTH
APLS

The current LNTH Sharpe Ratio is 1.04, which is higher than the APLS Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of LNTH and APLS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JulyAugustSeptemberOctoberNovemberDecember
1.04
-0.70
LNTH
APLS

Dividends

LNTH vs. APLS - Dividend Comparison

Neither LNTH nor APLS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

LNTH vs. APLS - Drawdown Comparison

The maximum LNTH drawdown since its inception was -78.62%, which is greater than APLS's maximum drawdown of -74.65%. Use the drawdown chart below to compare losses from any high point for LNTH and APLS. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-26.27%
-63.54%
LNTH
APLS

Volatility

LNTH vs. APLS - Volatility Comparison

The current volatility for Lantheus Holdings, Inc. (LNTH) is 11.15%, while Apellis Pharmaceuticals, Inc. (APLS) has a volatility of 18.54%. This indicates that LNTH experiences smaller price fluctuations and is considered to be less risky than APLS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
11.15%
18.54%
LNTH
APLS

Financials

LNTH vs. APLS - Financials Comparison

This section allows you to compare key financial metrics between Lantheus Holdings, Inc. and Apellis Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab